Ecrins Therapeutics

About:

Discovering new drugs is both our profession and our passion.

Website: http://ecrins-therapeutics.com/en/home/

Twitter/X: ecrinsth

Top Investors: Eurostars

Description:

Ecrins Therapeutics is a privately held biotech company specialized in the discovery and development of innovative oncology drugs. Our main drug candidate ET-D5 is being developped for human and veterinary oncology applications and is currently in the regulatory preclinical phase. Our other R&D programs are in the discovery phase.

Total Funding Amount:

$2.67M

Headquarters Location:

Grenoble, Rhone-Alpes, France

Founded Date:

2010-01-01

Contact Email:

info(AT)ecrins-therapeutics.com

Founders:

Andreï Popov

Number of Employees:

1-10

Last Funding Date:

2015-05-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai